Related Experiment Videos

Verapamil treatment of canine hemorrhagic shock

R G Carroll1, S G Iams, P L Farmer

  • 1Department of Physiology, School of Medicine, East Carolina University, Greenville, North Carolina 27858-4354.

Insights

Verapamil, a calcium channel blocker, significantly prolonged survival and delayed decompensation in dogs experiencing hemorrhagic shock. This suggests calcium channel blockade is a promising treatment for this condition.

Area of Science:

  • Cardiovascular Physiology
  • Cellular Biology
  • Pharmacology

Background:

  • Calcium influx into ischemic cells initiates irreversible damage.
  • Hemorrhagic shock leads to cellular damage and decreased blood pressure.
  • Verapamil may inhibit calcium influx, potentially mitigating injury.

Purpose of the Study:

  • To investigate verapamil's effect on survival during hemorrhagic shock.
  • To determine if verapamil delays or reduces calcium influx-induced injury.
  • To assess verapamil as an intervention for hemorrhagic shock.

Main Methods:

  • Utilized chronically instrumented dogs subjected to rapid hemorrhage.
  • Administered verapamil before or after hemorrhage in different groups.
  • Monitored mean arterial blood pressure, decompensation time, and survival time.

Main Results:

  • Verapamil pretreatment significantly increased time to decompensation and survival time.
  • Verapamil initiated post-hemorrhage improved survival rate to 75%.
  • Verapamil did not affect initial arterial pressure recovery post-hemorrhage.

Conclusions:

  • Calcium channel blockade with verapamil shows potential as an initial treatment for hemorrhagic shock.
  • Verapamil's ability to prolong survival suggests a role in managing ischemic cellular damage.
  • Further research into verapamil's efficacy in hemorrhagic shock is warranted.

Related Concept Videos